This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments: a clinical phase I/II study
British Journal of Cancer Open Access 07 May 2002
-
Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for Pre-phase I positron emission tomography studies in cancer patients
British Journal of Cancer Open Access 02 April 2002
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Operation manual for control of production, preclinical toxicology and phase I trials of anti-tumour antibodies and drug antibody conjugates. Prepared by a Joint Committee of the: Cancer Research Campaign National Institute for Biological Standards and Control. Br J Cancer 54, 557–568 (1986). https://doi.org/10.1038/bjc.1986.209
Issue Date:
DOI: https://doi.org/10.1038/bjc.1986.209
This article is cited by
-
Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study
International Journal of Colorectal Disease (2005)
-
Tumour targeting of humanised cross-linked divalent-fab′ antibody fragments: a clinical phase I/II study
British Journal of Cancer (2002)
-
Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for Pre-phase I positron emission tomography studies in cancer patients
British Journal of Cancer (2002)
-
Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for Pre-phase I positron emission tomography studies in cancer patients
British Journal of Cancer (2002)